12 Biggest Mid-Day Losers For Friday

Loading...
Loading...
  • Cellect Biotechnology Ltd. - American Depositary Shares APOP fell 29.5 percent to $4.31. Cellect Biotechnology shares surged Thursday after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.
  • Uranium Resources, Inc. URRE shares dropped 25.2 percent to $2.35 after the company reported the pricing of $9.7 million public offering.
  • Skyline Medical Inc SKLN shares declined 19.5 percent to $2.27. Skyline Medical priced its stock and warrant offering for gross proceeds of $3.9 million.
  • Marinus Pharmaceuticals Inc MRNS shares fell 15.9 percent to $1.18. Marinus Pharmaceuticals shares have declined 75.99 percent over the past 52 weeks, while the S&P 500 index has climbed 20.11 percent in the same period.
  • Inventure Foods Inc SNAK declined 12.2 percent to $6.39. DA Davidson downgraded Inventure Foods from Buy to Neutral and lowered the price target from $10.00 to $8.00.
  • Ryerson Holding Corp RYI dropped 9.2 percent to $12.30. Ryerson projects Q4 loss of $14 million to $11 million including LIFO expense.
  • GameStop Corp. GME dropped 8.3 percent to $22.66. GameStop slashed its comparable sales guidance for the fourth quarter and full year after it reported “disappointing” holiday sales on industry weakness, pricing pressure and lower store traffic.
  • Biocept Inc BIOC shares fell 6.6 percent to $1.99. Biocept shares have dropped 55.35 percent over the past 52 weeks, while the S&P 500 index has climbed 20.11 percent in the same period.
  • Infosys Ltd ADR INFY shares declined 5.4 percent to $14.43. Infosys posted Q3 earnings of $0.24 per share on revenue of $2.55 billion.
  • MYOS RENS Technology Inc MYOS shares fell 4 percent to $3.60 after dropping 45.01 percent on Thursday.
  • Actuant Corporation ATU dropped 3 percent to $26.05. RBC Capital downgraded Actuant from Outperform to Sector Perform.
  • Alamos Gold Inc (US) AGI slipped around 3 percent to $8.15. Credit Suisse downgraded Alamos Gold from Outperform to Neutral.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsMovers & ShakersIntraday UpdateMarketsAnalyst RatingsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...